We are live on ! Find out more
NLVP

New Leaf Venture Partners Portfolio holdings

AUM $43M
1-Year Est. Return 25.55%
This Fund
S&P 500
This Quarter Est. Return
+8.64%
1 Year Est. Return
-25.55%
3 Year Est. Return
+17.13%
5 Year Est. Return
+114.46%
10 Year Est. Return
+1,011.57%
AUM
$185M
AUM Growth
-$28.6M
Cap. Flow
-$5.32M
Cap. Flow %
-2.87%
Top 10 Hldgs %
96.03%
Holding
18
New
2
Increased
2
Reduced
1
Closed
4

Top Buys

Rank Stock Value
1
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
+$6.3M
2
COGT icon
Cogent Biosciences
COGT
+$6.11M
3
AFMD
Affimed
AFMD
+$4.25M
4
CRSP icon
CRISPR Therapeutics
CRSP
+$3.63M

Top Sells

Rank Stock Value
1
IRTC icon
iRhythm Holdings
IRTC
+$18.4M
2
SAGE
Sage Therapeutics
SAGE
+$4.12M
3
ALDR
Alder Biopharmaceuticals
ALDR
+$1.96M
4
OTIC
Otonomy, Inc.
OTIC
+$610K
5
MRNS
Marinus Pharmaceuticals, Inc
MRNS
+$491K

Sector Composition

Rank Sector Weight
1 Healthcare 97.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DCPH
1
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$82.2M 44.41%
4,104,140
– –
CRSP icon
2
CRISPR Therapeutics
CRSP
$5.17B
$27.2M 14.7%
595,642
+87,912
+17% +$3.63M
WVE icon
3
Wave Life Sciences
WVE
$1.2B
$18.4M 9.92%
458,259
– –
OBSV
4
DELISTED
ObsEva SA Ordinary Shares
OBSV
$12M 6.49%
890,501
– –
OXFD
5
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$10.6M 5.73%
852,497
– –
SRRA
6
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$10.4M 5.61%
125,511
+55,555
+79% +$6.3M
COGT icon
7
Cogent Biosciences
COGT
$7.24B
$6.11M 3.3%
+137,500
New +$6.11M
AFMD
8
DELISTED
Affimed
AFMD
$4.16M 2.25%
+225,000
New +$4.25M
RSLS
9
DELISTED
ReShape Lifesciences Inc. Common Stock
RSLS
$3.77M 2.04%
1,239
– –
TRIL
10
DELISTED
Trillium Therapeutics Inc.
TRIL
$2.91M 1.57%
404,159
– –
AVEO
11
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$2.8M 1.51%
96,452
– –
PDSB icon
12
PDS Biotechnology
PDSB
$43.4M
$2.77M 1.49%
117,243
– –
MRNS
13
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$1.31M 0.71%
85,638
-20,612
-19% -$491K
DERM
14
DELISTED
Dermira, Inc.
DERM
$488K 0.26%
61,109
– –
IRTC icon
15
iRhythm Holdings
IRTC
$4.2B
– –
-328,741
Closed -$18.4M
SAGE
16
DELISTED
Sage Therapeutics
SAGE
– –
-25,000
Closed -$4.12M
OTIC
17
DELISTED
Otonomy, Inc.
OTIC
– –
-109,825
Closed -$610K
ALDR
18
DELISTED
Alder Biopharmaceuticals
ALDR
– –
-171,364
Closed -$1.96M

Similar funds

BAM
Broadcrest Asset Management Winter Park, Florida $44.1M AUM 4.51% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
WCPI
Wynnchurch Capital Partners IV Rosemont, Illinois $44.8M AUM 11.91% 1-Year Est. Return
WAMC
Western Asset Management Company Pasadena, California $45.2M AUM 6.96% 1-Year Est. Return
CC
Corton Capital Carrying Place, Ontario, Canada $40.7M AUM 52.32% 1-Year Est. Return
CIEP
Constellation Investimentos e Participacoes Sao Paulo, Brazil $46.7M AUM 23.3% 1-Year Est. Return
IPI
Inflection Point Investments London, United Kingdom $46.9M AUM 18.35% 1-Year Est. Return
VSAM
Value Star Asset Management Hong Kong $49.2M AUM 60.1% 1-Year Est. Return

New Leaf Venture Partners's Q1 2018 Portfolio in Review

As of Q1 2018, New Leaf Venture Partners held 18 positions worth $185M, down 13% from $214M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

New Leaf Venture Partners's Q1 2018 filing shows 2 new, 2 increased, 1 reduced and 4 closed positions. Its largest new stake was Cogent Biosciences: 137,500 shares worth $6.11M. The largest sale was iRhythm Holdings, an estimated $18.4M.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 96% a quarter earlier.

  • New Leaf Venture Partners's largest Q1 2018 buy was Cogent Biosciences: 137,500 shares worth $6.11M.
  • New Leaf Venture Partners added most to Sierra Oncology, Inc. Common Stock in Q1 2018, an estimated $6.3M increase.
  • New Leaf Venture Partners's biggest Q1 2018 reduction was Marinus Pharmaceuticals, Inc, cutting an estimated $491K.
  • New Leaf Venture Partners fully exited iRhythm Holdings in Q1 2018, selling an estimated $18.4M.
  • New Leaf Venture Partners's ten largest holdings make up 96% of its $185M portfolio in Q1 2018.
  • New Leaf Venture Partners opened 2 new positions and closed 4 in Q1 2018.
  • New Leaf Venture Partners's portfolio value fell 13% quarter-over-quarter to $185M.

Based on New Leaf Venture Partners's 13F filing for Q1 2018, filed 15 May 2018.